CONSENT AND EXCHANGE AGREEMENTConsent and Exchange Agreement • September 16th, 2014 • CorMedix Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 16th, 2014 Company Industry JurisdictionThis Consent and Exchange Agreement (the “Agreement”) is made as of this 15 day of September 2014, by and among CorMedix Inc., a Delaware corporation (the “Company”), and the undersigned holders (the “Holders”) of all of the outstanding warrants to purchase common stock, $0.001 par value, of the Company (the “Common Stock”) issued by the Company on March 10, 2014 (the “March 2014 Warrants”).
CONSENT AND EXCHANGE AGREEMENTConsent and Exchange Agreement • September 16th, 2014 • CorMedix Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 16th, 2014 Company Industry JurisdictionThis Consent and Exchange Agreement (the “Agreement”) is made as of this 15 day of September 2014, by and among CorMedix Inc., a Delaware corporation (the “Company”), and the undersigned holders (the “Holders”) of (i) all of the outstanding shares (the “Existing Series C-3 Stock”) of the Company’s non-voting convertible Series C-3 preferred stock (the “Series C-3 Preferred Stock”), and (ii) all of the outstanding warrants to purchase common stock, $0.001 par value, of the Company (the “Common Stock”) issued by the Company on January 7, 2014 (the “January 2014 Warrants”).